We verify everything in medicine. Why not verify intraosseous catheter placement?
SureWave IO Confirm leverages the intraosseous waveform analysis technique for confirmation of correct IO catheter placement, which was first described by Sabra Medical’s founder, Dr. Greenstein. The device is a self-calibrating, sterile, single-use, disposable physiological pressure transducer system with an integrated digital display capable of displaying a numerical and continuous waveform representation of pressure data in the intraosseous space. It connects directly to an intraosseous catheter and converts changes in pressure into a digital readout for immediate assessment of appropriate catheter placement.
SureWave IO Confirm is a class II device that will follow the FDA 510(k) pathway for approval.
Patents for the SureWave IO Confirm device were filed in April 2022, reflecting our commitment to innovation and intellectual property protection. These filings include US2022/0338752 A1 and WIPO Publication No. WO2022/226509, securing our advancements in intraosseous catheter placement technology on both national and international levels.
